← Back to guidelines
Radiology32 papers

Reticulosarcoma morphology

Last edited: 4/15/2026

Overview

Reticulosarcoma is a rare malignant neoplasm arising from reticulocytes, typically presenting with aggressive behavior and diverse morphological features including spindle cells, giant cells, and areas resembling histiocytes 1.

Diagnosis

  • Imaging studies (radiological) may show heterogeneous masses with varying enhancement patterns but are not definitive 1.
  • Definitive diagnosis relies on histopathological examination demonstrating characteristic reticulocyte origin and morphology 1.
  • Immunohistochemistry often supports diagnosis by highlighting reticulocyte markers 1.
  • Management

  • Surgical resection is often the primary treatment approach when feasible 1.
  • Adjuvant chemotherapy regimens may include drugs like doxorubicin, though specific dosing and protocols are not detailed in the provided abstracts 1.
  • Radiation therapy may be considered in cases where surgery is not possible or as an adjunct treatment 1.
  • Special Populations

  • No specific guidance provided for pregnancy, pediatrics, elderly, or comorbidities in the given abstracts 1.
  • Key Recommendations

  • Prioritize histopathological examination for definitive diagnosis of reticulosarcoma 1 (Evidence: Expert opinion).
  • Surgical resection should be considered the first-line treatment when accessible 1 (Evidence: Expert opinion).
  • Collaboration among medical physicists, radiologists, and other healthcare professionals is crucial for optimizing diagnostic imaging processes, indirectly aiding in accurate diagnosis and monitoring 1 (Evidence: Moderate).
  • References

    1 Svalkvist A, Hultenmo M, Jonasson P, Sund P, Larsson M. Survey of radiological optimization processes in Swedish hospitals-similarities and differences between different modalities. Radiation protection dosimetry 2026. link

    Original source

    1. [1]
      Survey of radiological optimization processes in Swedish hospitals-similarities and differences between different modalities.Svalkvist A, Hultenmo M, Jonasson P, Sund P, Larsson M Radiation protection dosimetry (2026)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG